HSPB8 and breast cancer: In agreement with these observations on BAG3 silencing, in the MCF-7 breast cancer (BC) cell line, HSPB8 silencing causes a block of the cell cycle in the G0/G1 phase and a decrease in cell proliferation, confirming that HSPB8 is involved in the mechanisms that regulate the cell cycle and cell proliferation [77].